Hepatitis c and liver transplantation

Research output: Book/ReportBook


This book provides a single reference for all transplant professionals involved in the care of HCV patients who have unique problems not encountered in other liver transplant patients. In the liver transplant community, it is well-known that decompensated cirrhosis from hepatitis C virus (HCV) is the leading indication for orthotopic liver transplantation (OLT) in the United States and most Western countries. Short-term results which initially seemed promising and comparable to other carefully selected liver transplant recipients now appear less encouraging with cirrhosis developing in 10-25% of patients by 5 years. Despite these concerns, there is an increased amount of data which supports re-transplantation in carefully selected patients.

Original languageEnglish (US)
PublisherNova Science Publishers, Inc.
Number of pages273
ISBN (Electronic)9781617611346
ISBN (Print)9781617286162
StatePublished - Jan 1 2010
Externally publishedYes

All Science Journal Classification (ASJC) codes

  • Medicine(all)


Dive into the research topics of 'Hepatitis c and liver transplantation'. Together they form a unique fingerprint.

Cite this